Table 3:
Recommendations by Professional Societies* for Management of Acute Exacerbations of COPD
Bronchodilators
American Thoracic Society
European Respiratory Society
British Thoracic Society
Global Initiative for Chronic Obstructive Lung Disease
Recommended:
Beta2-agonists +/- anticholinergics;
IV aminophylline if inadequate response
Recommended: Beta2-agonists +/- anticholinergics;
methylxanthines if needed as second line in severe exacerbations
Recommended:
Beta2-agonists +/- anticholinergics;
IV aminophylline if inadequate response
Recommended:
Beta2-agonist dose increase +/- anticholinergics +/- IV aminophylline depending on disease severity
Corticosteroids
Oral or systemic Oral or systemic empirically 7-14 days of systemic steroids Systemic steroids
Antibiotics
Narrow-spectrum antibiotic;
broad spectrum if no response
Inexpensive antibiotic empirically for 7-14 days;
if ineffective, choice guided by sputum culture
Common oral antibiotics usually adequate
Broader spectrum if no response or if more severe exacerbation.
Empirically with increased sputum volume and purulence based on local sensitivity patterns to usual pathogens
Oxygen Therapy
Raise PaO2> 60 mm Hg Keep SaO2 > 90% and/or PaO2 > 60 mm Hg. Avoid PaCO2 rise by > 10 mm Hg or pH drop to < 7.25 Raise PaO2 > 50 mm Hg while avoiding pH < 7.26 Keep SaO2 > 90% and PaO2 > 60 mm Hg
Ventillatory Support
NIPPV or invasive mechanical ventilation based on criteria NIPPV in appropriate patients NIPPV or invasive mechanical ventilation if pH < 7.26 with rising PaCO2 despite controlled oxygen therapy NIPPV or invasive mechanical ventilation based on selection and exclusion criteria.
Chest Physiotherapy
Only if sputum volume is > 25 ml/day Help in clearance of secretions Not recommended May be beneficial in certain circumstances
*Abbreviations for professional societies are in Table 1 footnote.
IV-Intravenous
NIPPV-Noninvasive positive pressure ventilation
Copyright 2002 The Cleveland Clinic Foundation

Return to Chronic Obstructive Pulmonary Disease Chapter